Speckle-tracking global longitudinal strain as an early predictor of cardiotoxicity in breast carcinoma
- 29 February 2016
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (7) , 3139-3145
Abstract
Recent development in anticancer therapies for breast carcinoma allowed an improvement in patients’ survival, notwithstanding a parallel increase of cardiovascular morbidity. Cardiotoxicity of anticancer therapies represents a relevant problem due to its insidious onset and potentially irreversible cardiac damage. The aim of the present study was to test whether 2D speckle tracking analysis can help in predicting overt systolic dysfunction.Keywords
Funding Information
- Università Politecnica delle Marche (166-2014)
This publication has 28 references indexed in Scilit:
- State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature reviewCritical Reviews in Oncology/Hematology, 2013
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2012
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and TrastuzumabCirculation: Cardiovascular Imaging, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2010
- Prediction of All-Cause Mortality From Global Longitudinal Speckle StrainCirculation: Cardiovascular Imaging, 2009
- Cardiovascular Complications of Cancer TherapyJACC, 2009
- Myocardial Strain Measurement With 2-Dimensional Speckle-Tracking EchocardiographyJACC: Cardiovascular Imaging, 2009
- Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose ChemotherapyCirculation, 2004
- Cardiac Dysfunction in the Trastuzumab Clinical Trials ExperienceJournal of Clinical Oncology, 2002